Corcept Therapeutics
CORT
#2106
Rank
HK$73.50 B
Marketcap
HK$684.68
Share price
3.03%
Change (1 day)
19.13%
Change (1 year)

EPS for Corcept Therapeutics (CORT)

EPS in 2026 (TTM): HK$3.51

According to Corcept Therapeutics 's latest financial reports the company's current EPS (TTM) is HK$3.53. In 2025 the company made an earnings per share (EPS) of HK$7.37 a decrease over its 2024 EPS that were of HK$10.59.

EPS history for Corcept Therapeutics from 2017 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$3.51-52.42%
2025HK$7.37-30.37%
2024HK$10.59
2022HK$7.45-2.06%
2021HK$7.615.43%
2020HK$7.2110.84%
2019HK$6.5127.69%
2018HK$5.10-42.48%
2017HK$8.86

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.50 1,841.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$55.04 1,460.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.27 191.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$221.32 6,172.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$27.89 690.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$27.91 691.11%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
HK$0.16-95.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-HK$3.92-211.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$10.98 211.11%๐Ÿ‡บ๐Ÿ‡ธ USA